Pharmaron Beijing Co., Ltd. (SHE:300759)
China · Delayed Price · Currency is CNY 36.80
+0.79 (2.19%)
Jul 31, 2026, 3:04 PM CST
Pharmaron Beijing Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Pharmaron Beijing stock has a consensus rating of "Buy" and an average price target of ¥37.73. The average 1-year stock price forecast is 2.53% higher than the current stock price, while the lowest is ¥23.80 (-35.33%) and the highest is ¥46.16 (+25.43%).
Price Target: ¥37.73 (+2.53%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Pharmaron Beijing stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 8 | 8 | 7 | 7 |
| Buy | 3 | 3 | 3 | 2 | 2 | 3 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 13 | 14 | 13 | 12 | 13 |
Financial Forecast
Revenue This Year
16.48B
from 14.10B
Increased by 16.90%
Revenue Next Year
18.90B
from 16.48B
Increased by 14.73%
EPS This Year
1.12
from 0.87
Increased by 28.90%
EPS Next Year
1.37
from 1.12
Increased by 22.29%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.